Outlook Therapeutics (OTLK) Total Liabilities: 2015-2019
Historic Total Liabilities for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $27.9 million.
- Outlook Therapeutics' Total Liabilities fell 44.24% to $19.3 million in Q2 2020 from the same period last year, while for Jun 2020 it was $19.3 million, marking a year-over-year decrease of 44.24%. This contributed to the annual value of $27.9 million for FY2019, which is 35.25% down from last year.
- According to the latest figures from FY2019, Outlook Therapeutics' Total Liabilities is $27.9 million, which was down 35.25% from $43.1 million recorded in FY2018.
- In the past 5 years, Outlook Therapeutics' Total Liabilities ranged from a high of $62.6 million in FY2015 and a low of $27.9 million during FY2019.
- Over the past 3 years, Outlook Therapeutics' median Total Liabilities value was $43.1 million (recorded in 2018), while the average stood at $40.8 million.
- In the last 5 years, Outlook Therapeutics' Total Liabilities plummeted by 51.12% in 2016 and then spiked by 68.29% in 2017.
- Over the past 5 years, Outlook Therapeutics' Total Liabilities (Yearly) stood at $62.6 million in 2015, then plummeted by 51.12% to $30.6 million in 2016, then soared by 68.29% to $51.5 million in 2017, then decreased by 16.26% to $43.1 million in 2018, then crashed by 35.25% to $27.9 million in 2019.